Photo Release -- Napa Valley Nutritionals Launches Two New Glucorein(TM) Chlorogenic-Acid Products -- Robusta/Arabica Blend and Brazilian Decaf

Glucorein Medical Food Designed for Dietary Management of Glucose Levels in Pre-Diabetics and Type 2 Diabetics

SACRAMENTO, Calif., June 14, 2012 (GLOBE NEWSWIRE) -- Napa Valley Nutritionals (www.nvnutritionals.com) today introduced two Glucorein™ chlorogenic-acid coffee drinks—Brazilian Decaf and Robusta/Arabica Blend—intended for the dietary management of glucose levels in both pre-diabetics and type 2 diabetics. Initially made available in a decaffeinated green-tea formulation in March of this year, the Glucorein family of proprietary chlorogenic acid beverages for pre-diabetics and type 2 diabetics contain no artificial sweeteners or calories, and are formulated with all natural ingredients.

Brazilian Decaf Coffee Blend


Robusta Arabica Coffee Blend


Photos accompanying this release are available at

https://www.globenewswire.com/newsroom/prs/?pkgid=13279

https://www.globenewswire.com/newsroom/prs/?pkgid=13280

Glucorein coffee and tea drinks, formulated with chlorogenic acid, are a proprietary medical food designed to decrease intestinal glucose absorption and reduce the rate of liver glycogenolysis in the body.   

"I believe the introduction of Glucorein into the daily diet of both pre-diabetics and type 2 diabetics could be one of the most important advances in the treatment of this affliction in the past few decades," said Dr. Adam Landsman, assistant professor of surgery at Harvard Medical School. "Glucorein chlorogenic acid is proven effective in minimizing blood sugar spikes. In combination with a reasonable diet and exercise—under the supervision of a medical professional—it could eliminate the need for diabetic drugs in many patients."

The Science of Chlorogenic Acid

A significant body of evidence exists which provides clear data on the mechanisms of action at work, the activity of, and impact chlorogenic acids may have with respect to blood glucose management:

  • G-6-Pase translocase inhibitors such as chlorogenic acid may be useful for the reduction of inappropriately high rates of hepatic glucose output often found in type 2 (non-insulin dependent) diabetics and obese individuals.
     
  • Strong plasma antioxidants, such as chlorogenic acid, may reduce LDL oxidation, positively impacting the quality of life of diabetic patients.
     
  • Chlorogenic acid's ability to affect gastrointestinal hormones may delay glucose uptake in the small intestine and shift the site of glucose absorption to more distal parts of the intestine.
     
  • Scientific studies have demonstrated that coffee consumption may have an inverse associated risk with developing type 2 diabetes.
     
  • Chlorogenic acid has also demonstrated the ability to provide a slimming effect versus a placebo.
     
  • A comprehensive list of chlorogenic acid studies as they relate to diabetes is available at www.nvnutritionals.com/glucorein/studies.

Ordering Information

Glucorein, to be used under the supervision of a medical professional, can be ordered by phoning 1-888-259-6599 or visiting the web site at www.nvnutrionals.com/glucorein. Typically, physicians recommend a single serving of Glucorein tea or coffee per day. The suggested retail price is $99 for a thirty-day supply.   

About Napa Valley Nutritionals

Napa Valley Nutritionals, a division of Oculus Innovative Sciences, develops and manufactures medical foods, which combine the best of science and nature. Established in 2011, the company's inaugural family of products is formulated with the clinically proven Glucorein™ chlorogenic acid. The company is headquartered in Sacramento, California. More information can be found at www.nvnutritionals.com.  

High-resolution product photos are available. Please call or email request.

CONTACT: Napa Valley Nutritionals
         Dan McFadden
         Director of Marketing/Communications
         (425) 753-2105
         dmcfadden@nvnutritionals.com
Source: Oculus Innovative Sciences, Inc.